Revascularization Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Revascularization clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
Yonsei University4,310 enrolled1 locationNCT05782777
Recruiting

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

Coronary Artery Bypass GraftingCoronary Artery Disease ProgressionCoronary Stenosis+1 more
Seung-Jung Park200 enrolled1 locationNCT03788369
Recruiting
Not Applicable

Study on the Trans-Carotid Artery Occlusion Shunt System

Carotid Artery StenosisRevascularizationCarotid Artery Diseases
Shenzhen Wecan Medical Technology Co.,Ltd162 enrolled1 locationNCT06924593
Recruiting

Effects of Personalised Exercise Rehabilitation FOR people with Multimorbidity and cardiac or pulmonary disease: the PERFORM-CPR trial.

Post myocardial infarctionPost cardiac revascularizationCancer+3 more
Monash University604 enrolled8 locationsACTRN12624001191583
Recruiting
Not Applicable

Outcome of Pulp Revascularization of Necrotic Mature Permanent Teeth Using Platelet-rich Fibrin

Pulp Revascularization
King Abdullah University Hospital50 enrolled1 locationNCT06347640
Recruiting
Not Applicable

Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB)

Heart FailureRevascularization
Assistance Publique - Hôpitaux de Paris1,040 enrolled1 locationNCT05532631
Recruiting

The Evolution and Prognosis of Moyamoya Disease

Cognitive ImpairmentMoyamoya DiseaseRevascularization+1 more
Chinese PLA General Hospital300 enrolled1 locationNCT05619068